OHSU in the news

OHSU addresses dentist opioid prescriptions as a path to abuse

Portland Business Journal November 08, 2022
Richie Kohli, B.D.S, M.S., and Karan Replogle, D.D.S., M.S., describe the live video pain management and substance use disorder training they organize for dental professionals. Kohli says: “It’s important we talk to patients about what are other alternatives before we prescribe opioids, so patients can make a good, informed decision.”

RSV and flu are back. Here’s what Oregonians should know

Oregon Public Broadcasting November 08, 2022
In an OPB story about rising cases of RSV among infants and toddlers, Eliza Hayes Bakken, M.D., says, “Babies can literally look like they are kind of drowning in snot. Suctioning them so they can get some breaths through their nose and they can feel a little bit better is one of our major interventions.”

How to know if breathwork is right for you

Mashable November 06, 2022
In a story about yoga and meditation practices, Mashable cites new research from Selda Yildiz, Ph.D., suggesting that different yogic breathing patterns can improve the movement and circulation of cerebrospinal fluid.

Oregon Health & Science University performs brain surgery in clinical trial for epilepsy

The Columbian November 05, 2022
OHSU is the second center in the country to implant interneurons in the brain as part of a clinical trial to treat an intractable form of epilepsy. Kim Burchiel, M.D., says he is optimistic the procedure will become a more routine option along with current standard forms of surgical intervention, including implanted stimulators or resection. He says, “Where I see us moving now is into more of what I would call the restorative era. Neural restoration – the idea being, don’t remove it, don’t necessarily use electrical impulses to try to modify it – but try to restore it. And that, to me, I think it’s the Holy Grail right now of what we do in neurology and neurosurgery.”

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

Cancer Network November 05, 2022
In an Oncology Times story on the American Association for Cancer Research’s annual progress report, current AACR President Lisa Coussens, Ph.D., says the “revolution in immune therapies,” has allowed cancer patients who previously would have died within 2 years of their diagnoses to live for 15 years or longer.

New AACR Report Showcases Progress Against Cancer, Issues Call to Action

Oncology Times November 05, 2022
In an Oncology Times story on the American Association for Cancer Research’s annual progress report, current AACR President Lisa Coussens, Ph.D., says the “revolution in immune therapies,” has allowed cancer patients who previously would have died within 2 years of their diagnoses to live for 15 years or longer.
See more stories